@NCI

Citius (CTXR) Expands Scientific Advisory Board. Dr. John Laffey, Expert in Stem Cell and...

- Addition of leading scholar and KOL in acute respiratory distress syndrome (ARDS) to ARDS Scientific Advisory Board supports continued progress of Citius' novel...
Biotech Stock Review

Adding Immunomedics (IMMU) $3.00 to Watch List.

Biotech Stock Review Initiates Coverage. Immunomedics (IMMU). $3.00 Epic Short Squeeze Inflection Point Nears. As posted on SeekingAlpha.

Adding Sekur Private Data (SWISF) to Watch List.

WhatsApp & Gmail Competitor That's Secure. LIVE QUOTE Our First Cyber-Security Play in a Long Time. Looks Interesting. Sekur is a private and secure messaging and email...

Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study of Cancer Immunotherapy.

Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study of Cancer Immunotherapy I/ONTAK (E7777) for the Treatment of Persistent or Recurrent Cutaneous...

Medtech Incubator in Final Stages of Launch.

TrueNature (TNTY) Has Spent the Past Year Gearing Up. News of a Launch and First Incubation Effort Could be Around the Corner and Attract...

Revive (RVVTF) Hits a Snag?

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19 First our summary."FDA provided communication that the amended protocol is still under...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever! We're adding Citius Pharma to the Watch...

Adding Principal Solar (PSWW) to Watch List.

LIVE QUOTE Principal Solar Website And we found another Incubator! This one acquiring stakes in technologies that support next-generation opportunities in traditional, renewable, and clean energy...

Maxim Group Targets 175% Gain in Society Pass (SOPA) to $2.75.

If we average out the two most recent price targets this month, we come out with a potential gain of 337% and that ain't...
Immunomedics, Biotech Stock Review

Immunomedics (IMMU) $33 | Raising Price Potential to $60. American BriVision (ABVC) $3.00 |...

We Are Raising the Price Potential of Immunomedics (IMMU) to $60, Highest on the Street, and Initiating Coverage on Another $3.00 Medical Start-Up American...

Latest article

Adding BCM Resources Corporation (B.V) $0.27, Up 42%, to Watch List.

'Elephant Hunter' Dr. Sergei Diakov is Expanding Drill Footprint, to Outline a Potentially Massive Copper-Gold System Beneath the Surface. Led by legendary geologist Dr. Sergei...

New Report on Sekur Private Data (SWISF). Palantir’s Open Secure AI.

Palantir CEO Alex Karp discusses open-weight artificial intelligence models, how he believes the technology should be regulated and why the U.S. should avoid Europe’s...

Replimune (REPL) Jumps 100%.

A Nifty $415 Million Gain (in an hour) for Shareholders. Not out of the woods yet.. Short and to the point: We listened to whole meeting...